Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK) - a Prospective Companion Study for Patients With Cancer and COVID-19

NCT04603105 is registered in ClinicalTrials.gov with The Clatterbridge Cancer Centre NHS Foundation Trust as lead sponsor.

NCT NCT04603105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04603105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK) - a Prospective Companion Study for Patients With Cancer and COVID-19
Lead sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Phase
Observational
Overall status
Active, not recruiting
Start date
February 28, 2021
Completion date
October 31, 2025
Enrollment
9,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, covid19